Glenmark receives ANDA final approval for Tadalafil Tablets

▴ Glenmark receives ANDA final approval for Tadalafil Tablets
Glenmark has also received tentative approval by the U.S. FDA for Gabapentin Enacarbil Extended-Release Tablets, the generic version of Horizant 1of Arbor Pharmaceuticals.

Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg, the generic version of Cialis 1 Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg, of Eli Lilly and Company.

According to IQVIA sales data for the 12 month period ending November 2020, the Cialis Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg market2 achieved annual sales of approximately $125.5 million*.

Glenmark has also received tentative approval by the U.S. FDA for Gabapentin Enacarbil Extended-Release Tablets, 300 mg and 600 mg, the generic version of Horizant 1 Extended-Release Tablets, 300 mg and 600 mg, of Arbor Pharmaceuticals, LLC. The Horizant market achieved annual sales of approximately $99.5 million.

Additionally, Glenmark has received tentative approval for Apremilast Tablets, 10 mg, 20 mg and 30 mg, the generic version of Otezla Tablets, 10 mg, 20 mg and 30 mg, of Amgen, Inc. The Otezla Tablets, 10 mg, 20 mg and 30 mg market achieved annual sales of approximately $2.7 billion.

Glenmark’s current portfolio consists of 167 products authorized for distribution in the U.S. marketplace and 44 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Tags : #LatestPharmaNewsDec31 #LatestGlenmarkNewsDec31 #Treatmentforerectiledysfunction

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

India’s First Indigenous CAR T-Cell Therapy Launched By President Droupadi Murmu: A New Hope in Cancer TreatmentApril 12, 2024
Investigation Launched After Cataract Surgery Patients Experience Side-Effects in IndoreApril 12, 2024
The Reality of Protein Supplements in India: Mislabeling, Toxins, and Quality ChallengesApril 12, 2024
Fighting Tuberculosis: IHLD and Krafton India Join Forces for Active Case DetectionApril 11, 2024
ICMR Study Reveals Blood Pressure Monitoring Gaps in IndiaApril 11, 2024
Innovative Procedure at KGMU Saves Man Impaled by Iron Rod: Beating Heart Surgery SuccessApril 11, 2024
Heart-Healthy Choices: How Salt Substitutes Can Prolong Your LifeApril 11, 2024
Unveiling Cancer Patterns in Families of Men with Fertility ChallengesApril 11, 2024
10 secrets of Successful Healthcare Branding and advertising campaignsApril 10, 2024
Global Hepatitis Crisis: India Ranks Second in Cases – WHO Report 2024April 10, 2024
Accelerated Ageing and Cancer Risk: New Perspectives from AACR 2024April 10, 2024
Man Hospitalized with Rare Bacterial Infection After Rat Bite: What You Need to KnowApril 10, 2024
Enhanced rock weathering results in higher crop yields and improved crop healthApril 09, 2024
Unlocking Health and Wealth - The Intersection of Digital Innovation in Healthcare and Finance for a Resilient IndiaApril 09, 2024
University of Exeter announces scholarships valued at over £10,000 for Indian StudentsApril 09, 2024
Thai Lion Air Extends Ground Handling Partnership with Çelebi India for Handling Cochin OperationsApril 09, 2024
Inclusion Carnival Illuminates Abilities and Awareness: A Vibrant Celebration of DiversityApril 08, 2024
Innovative Methodology in Heart Bypass Surgery: A Game-Changer in Cardiovascular MedicineApril 08, 2024
Shocking Study Reveals Link Between Alcohol and Heart Disease Risk in WomenApril 08, 2024
Is India Emerging As The Cancer Capital Of The World?April 08, 2024